{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:51:10Z","timestamp":1784609470669,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,21]],"date-time":"2017-10-21T00:00:00Z","timestamp":1508544000000},"content-version":"am","delay-in-days":262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31200808"],"award-info":[{"award-number":["31200808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571080"],"award-info":[{"award-number":["81571080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573416"],"award-info":[{"award-number":["81573416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["CG2013003005"],"award-info":[{"award-number":["CG2013003005"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["GCC2014015"],"award-info":[{"award-number":["GCC2014015"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2015206240"],"award-info":[{"award-number":["H2015206240"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neuropharm.2016.07.008","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T21:29:17Z","timestamp":1476653357000},"page":"241-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"PA","title":["Multiple target of hAmylin on rat primary hippocampal neurons"],"prefix":"10.1016","volume":"113","author":[{"given":"Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-0371","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.07.008_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuro.2014.01.001","article-title":"Involvement of TRPV4 channels in Abeta(40)-induced hippocampal cell death and astrocytic Ca(2+) signalling","volume":"41","author":"Bai","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib4","doi-asserted-by":"crossref","first-page":"e39959","DOI":"10.1371\/journal.pone.0039959","article-title":"The increased activity of TRPV4 channel in the astrocytes of the adult rat hippocampus after cerebral hypoxia\/ischemia","volume":"7","author":"Butenko","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.febslet.2013.03.014","article-title":"Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates","volume":"587","author":"Calamai","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib6","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00125-008-1111-z","article-title":"Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4","volume":"51","author":"Casas","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib7","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0168-8227(92)90074-2","article-title":"Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"15","author":"Enoki","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0196-9781(92)90092-H","article-title":"Differential effects of amylin on memory processing using peripheral and central routes of administration","volume":"13","author":"Flood","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib10","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib12","doi-asserted-by":"crossref","first-page":"a003962","DOI":"10.1101\/cshperspect.a003962","article-title":"The role of transient receptor potential cation channels in Ca2+ signaling","volume":"2","author":"Gees","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0006-291X(88)80538-2","article-title":"Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein","volume":"155","author":"Glenner","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00018-009-9070-1","article-title":"Common features between diabetes mellitus and Alzheimer's disease","volume":"66","author":"Gotz","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnagi.2013.00038","article-title":"Lessons from two prevalent amyloidoses-what amylin and Abeta have in common","volume":"5","author":"Gotz","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib19","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbamem.2007.01.022","article-title":"Membrane interaction of islet amyloid polypeptide","volume":"1768","author":"Jayasinghe","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10495-011-0656-3","article-title":"beta-Amyloid protein (Abeta) and human amylin regulation of apoptotic genes occurs through the amylin receptor","volume":"17","author":"Jhamandas","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12035-014-8992-2","article-title":"Activation of transient receptor potential vanilloid 4 is involved in neuronal injury in middle cerebral artery occlusion in mice","volume":"53","author":"Jie","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJM198908243210806","article-title":"Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus","volume":"321","author":"Johnson","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib23","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tins.2008.12.006","article-title":"Hot flash: TRPV channels in the brain","volume":"32","author":"Kauer","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib25","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1074\/jbc.275.19.14077","article-title":"Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line","volume":"275","author":"Kawahara","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10735-014-9578-z","article-title":"Age-related changes in the distribution of transient receptor potential vanilloid 4 channel (TRPV4) in the central nervous system of rats","volume":"45","author":"Lee","year":"2014","journal-title":"J.\u00a0Mol. Histol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","article-title":"Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures","volume":"582","author":"Lim","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0006-8993(95)00148-J","article-title":"Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium","volume":"676","author":"Mattson","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib31","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","article-title":"Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity","volume":"61","author":"May","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib32","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","article-title":"Pore formation by the cytotoxic islet amyloid peptide amylin","volume":"271","author":"Mirzabekov","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/diab.39.5.639","article-title":"Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration","volume":"39","author":"Mitsukawa","year":"1990","journal-title":"Diabetes"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2016.07.008_bib34","doi-asserted-by":"crossref","first-page":"83P","DOI":"10.1254\/fpj.112.supplement_83","article-title":"Amyloidogenic peptides such as beta-amyloid, amylin and calcitonin strongly enhance the susceptibility of rat hippocampal neurons to excitatory amino acids in\u00a0vivo","volume":"112","author":"Morimoto","year":"1998","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0196-9781(91)90148-I","article-title":"Amylin decreases food intake in mice","volume":"12","author":"Morley","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1139\/y95-147","article-title":"Effects of amylin on appetite regulation and memory","volume":"73","author":"Morley","year":"1995","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib37","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/emboj\/17.15.4274","article-title":"A\u00a0novel capacitative calcium entry channel expressed in excitable cells","volume":"17","author":"Philipp","year":"1998","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.07.008_bib38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/18715273113126660167","article-title":"Current view from alzheimer disease to type 2 diabetes mellitus","volume":"13","author":"Rasool","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib40","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1523\/JNEUROSCI.4284-06.2007","article-title":"Effects of body temperature on neural activity in the hippocampus: regulation of resting membrane potentials by transient receptor potential vanilloid 4","volume":"27","author":"Shibasaki","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0166-2236(88)90194-4","article-title":"Multiple types of neuronal calcium channels and their selective modulation","volume":"11","author":"Tsien","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0302s26","article-title":"Long-term culture of hippocampal neurons","author":"Vicario-Abejon","year":"2004","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib44","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.febslet.2009.07.044","article-title":"Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts","volume":"583","author":"Wakabayashi","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2016.07.008_bib45","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"Yaffe","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib46","doi-asserted-by":"crossref","first-page":"e38191","DOI":"10.1371\/journal.pone.0038191","article-title":"Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.07.008_bib47","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.bbamem.2012.08.012","article-title":"Probing ion channel activity of human islet amyloid polypeptide (amylin)","volume":"1818","author":"Zhao","year":"2012","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T12:13:57Z","timestamp":1712319237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816302945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":47,"alternative-id":["S0028390816302945"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.008","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple target of hAmylin on rat primary hippocampal neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}